Detalhe da pesquisa
1.
Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.
BMC Cancer
; 23(1): 410, 2023 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37149594
2.
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 716-726, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857411
3.
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 19(4): 461-473, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29501366
4.
Disrupting SOD1 activity inhibits cell growth and enhances lipid accumulation in nasopharyngeal carcinoma.
Cell Commun Signal
; 16(1): 28, 2018 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29891006
5.
Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
BMC Cancer
; 17(1): 134, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202000
6.
A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment interleukin 6 and clinical stage.
Clin Immunol
; 164: 45-51, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26780676
7.
Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma.
Cancer Cell Int
; 16: 54, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27382361
8.
Clinical outcome and predictive factors of irradiation-associated myasthenia gravis exacerbation in thymomatous patients.
Neurol Sci
; 36(11): 2121-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26209927
9.
Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.
Chin J Cancer
; 34(6): 237-46, 2015 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26067059
10.
Combination strategy exploration for prior treated recurrent or metastatic nasopharyngeal carcinoma in the era of immunotherapy.
Sci Rep
; 14(1): 1768, 2024 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242940
11.
Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial.
Nat Commun
; 15(1): 949, 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297016
12.
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial.
Nat Commun
; 15(1): 1029, 2024 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310101
13.
Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.
BMJ
; 385: e077890, 2024 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38897625
14.
Clinical features and treatment response of solid neuroendocrine breast carcinoma to adjuvant chemotherapy and endocrine therapy.
Breast J
; 19(4): 382-7, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23721399
15.
Favorable prognosis of female patients with nasopharyngeal carcinoma.
Chin J Cancer
; 32(5): 283-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22980419
16.
Anti-PD1 rechallenge in combination with anti-angiogenesis or anti-EGFR treatment beyond progression in recurrent/metastatic nasopharyngeal carcinoma patients.
Crit Rev Oncol Hematol
; 190: 104113, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633346
17.
Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor.
Front Immunol
; 14: 1069010, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733479
18.
Effective of metastasis-directed therapy for de novo metastatic nasopharyngeal carcinoma: A propensity score matched analysis.
Head Neck
; 45(10): 2571-2579, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37554098
19.
Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma.
Front Immunol
; 14: 1124066, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36860875
20.
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study.
EClinicalMedicine
; 62: 102136, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37593221